Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/13/2011 | US20110250643 Antibody composition-producing cell |
10/13/2011 | US20110250642 Method for Displaying Antibodies |
10/13/2011 | US20110250641 Zwitterionic acid-labile surfactants and methods of use |
10/13/2011 | US20110250640 Method of recloning production cells |
10/13/2011 | US20110250639 Methods for producing soluble membrane-spanning proteins |
10/13/2011 | US20110250638 Lignocellulosic biomass conversion |
10/13/2011 | US20110250624 Elisa assay for detecting antibodies against blv surface antigen gp 51 in bovine serum |
10/13/2011 | US20110250609 Methods For The Detection, Analysis And Isolation Of Nascent Proteins |
10/13/2011 | US20110250236 Stem cells derived from the carotid body and uses thereof |
10/13/2011 | US20110250220 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof |
10/13/2011 | US20110250210 Neutralizing Antibodies and Fragments Thereof Directed Against Platelet Factor-4 Variant 1 (PF4V1) |
10/13/2011 | US20110250203 Anti-cd5 antibodies |
10/13/2011 | US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling |
10/13/2011 | US20110250195 Antibodies Against IL-25 |
10/13/2011 | US20110250194 Treatment with Anti-ErbB2 Antibodies |
10/13/2011 | US20110250181 Human lysosomal proteins from plant cell culture |
10/13/2011 | US20110250130 Tnf-alpha binding proteins |
10/13/2011 | CA2794709A1 Selection and use of host cells for production of glycoproteins |
10/13/2011 | CA2794697A1 High mannose glycans |
10/12/2011 | EP2374894A2 A method for producing influenza hemagglutinin multivalent vaccines |
10/12/2011 | EP2374883A1 Anti-cd4 antibody |
10/12/2011 | EP2374881A1 Method for producing antibody directed against protein expressed on cell surface |
10/12/2011 | EP2374872A2 A method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification |
10/12/2011 | EP2374868A1 Cyclic penta-depsipeptide and fusarium sp. microorganism producing the same |
10/12/2011 | EP2374811A1 IgG Fc/HIV-gp120/c3d fusion protein |
10/12/2011 | EP2373787A1 Process for production of an enzymatic preparation for hydrolysis of cellulose from lignocellulosic residues and application thereof in the production of ethanol |
10/12/2011 | EP2184293B1 Suppression of resistance in insects to bacillus thuringiensis cry toxins, using toxins that do not require the cadherin receptor |
10/12/2011 | EP2146589B1 Whey protein hydrolysate |
10/12/2011 | EP1191096B1 Ovel protein and dna thereof |
10/12/2011 | CN102216466A Filamentous fungi with impaired ptrb activity for altered protein production |
10/12/2011 | CN102216324A Peptide synthesis using enzymatic activation and coupling |
10/12/2011 | CN102212600A Method for preparing antioxidant peptides from oats by utilizing enzymatic membrane reactor |
10/12/2011 | CN102212599A Method for preparing oat ACE (Angiotensin Converting Enzyme) inhibitory peptide by using enzymatic membrane reactor |
10/12/2011 | CN102212598A Method for preparing quaternary ammonium hydrolysis wheat peptide concentrated solution from gluten |
10/12/2011 | CN102212597A Method for producing collagen polypeptide, natural pigment and fish oil by using fish skin and fish scale |
10/12/2011 | CN102212596A Preparation method of human epidermal growth factor |
10/12/2011 | CN102212547A Intestinal trefoil factor recombinant expression vector and preparation method of intestinal trefoil factor |
10/12/2011 | CN102212132A Binding molecules capable of neutralizing rabies virus and uses thereof |
10/12/2011 | CN102212131A Binding molecules capable of neutralizing rabies virus and uses thereof |
10/12/2011 | CN102212126A Recombinant EDI (Endothelial Genesis Inhibitor)-8t protein with endothelial cell growth inhibiting activity |
10/12/2011 | CN102212107A Rice protein polypeptide and preparation method thereof |
10/12/2011 | CN102210860A Mycobacterium tuberculosis TB10.4-F1 fusion protein vaccine and preparation method thereof |
10/12/2011 | CN102210852A Treatment of T-cell mediated diseases |
10/12/2011 | CN101921328B Antifreeze polypeptide prepared by enzymolysis of cow leather collagen by alkali protease |
10/12/2011 | CN101921311B Anti-freeze polypeptide prepared by enzymolysis of cow leather collagen through papain |
10/11/2011 | US8034919 Probe, probe set, probe carrier, and testing method |
10/11/2011 | US8034918 Probe, probe set, probe carrier, and testing method |
10/11/2011 | US8034910 SUMO fusion protein expression system for producing native proteins |
10/11/2011 | US8034907 Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides |
10/11/2011 | US8034905 Anti-VEGF antibody compositions and methods |
10/11/2011 | US8034904 First therapeutic agent is an antibody or an epitope-binding fragment having the same amino acid sequence as the murine antibody EM164 produced by mouse hybridoma EM164; a second therapeutical agent selected from carboplatin, oxaliplatin, cisplatin, paclitaxel, docetaxel etc.; anticarcinogenic agents |
10/11/2011 | US8034903 Degraded TPO agonist antibody |
10/11/2011 | US8034902 Recombinant antibodies against CD55 and CD59 and uses thereof |
10/11/2011 | US8034784 Method of suppressing or reducing IL-TIF-induced inflammation, or treating associated conditions thereof, using Zcytor16 |
10/11/2011 | US8034772 Inhibitor of vascular endothelial cell growth factor |
10/11/2011 | US8034614 Fluorescent protein |
10/11/2011 | US8034604 High viscosity xanthan polymer preparations |
10/11/2011 | US8034598 Engineered cleavage half-domains |
10/11/2011 | US8034593 Multimeric oxidoreductases |
10/11/2011 | US8034590 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
10/11/2011 | US8034585 Superagonistic anti-CD28 antibodies |
10/11/2011 | US8034584 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
10/11/2011 | US8034583 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
10/11/2011 | US8034582 Process for crosslinking proteins with a ketose containing 3 to 5 carbon atoms |
10/11/2011 | US8034581 Cell-free extract and glycoprotein synthesis system |
10/11/2011 | US8034579 Proteins with enhanced functionality and methods of making novel proteins using circular permutation |
10/11/2011 | US8034358 Surface antigen |
10/11/2011 | US8034354 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
10/11/2011 | US8034346 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same |
10/11/2011 | US8034343 Methods of treating inflammatory disorders of the lungs |
10/11/2011 | US8034342 for treating degenerative cartilaginous disorders and other inflammatory diseases; interleukin-17 receptor protein |
10/11/2011 | US8034338 Immunogenic recombinant antibody |
10/11/2011 | US8034337 Interleukin-1α antibodies |
10/11/2011 | US8034330 Modified organs and cells for xenotransplantation |
10/11/2011 | US8034259 Inorganic particle conjugates |
10/11/2011 | CA2575519C Detection of truncation mutations by mass spectrometry |
10/11/2011 | CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor |
10/11/2011 | CA2427665C Method for the production of a heterologous protein by a fungus |
10/11/2011 | CA2157932C Production of human papillomavirus capsid protein and virus-like particles |
10/06/2011 | WO2011123811A2 Production of post-translationally hydroxylated recombinant proteins in bacteria |
10/06/2011 | WO2011123139A1 High level expression of recombinant crm197 |
10/06/2011 | WO2011122722A1 Method for preparing cholesterol oxidase, method for producing a plant sterol ferment using cholesterol oxidase, and functional composition, food and functional health food for reducing body fat using the plant sterol ferment |
10/06/2011 | WO2011121768A1 Novel cellulase gene |
10/06/2011 | WO2011120498A1 Method for process-managing a reactant-limited, biochemical reaction |
10/06/2011 | WO2011100566A3 Methods for identifying and isolating cells expressing a polypeptide |
10/06/2011 | WO2011065928A9 Processes for accelerating plant growth and increasing cellulose yield |
10/06/2011 | US20110247102 Constitutive promoters from poplar and uses thereof |
10/06/2011 | US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins |
10/06/2011 | US20110245474 Methods for g-csf production in a pseudomonas host cell |
10/06/2011 | US20110245472 Method for the mass production of immunoglobulin constant region |
10/06/2011 | US20110245326 Post-Transcriptional Regulation Of RNA-Related Processes Using Encoded Protein-Binding RNA Aptamers |
10/06/2011 | US20110245186 Recombinant e-selectin made in insect cells |
10/06/2011 | US20110245185 APO-2 ligand/trail formulations |
10/06/2011 | US20110245093 Functional protein arrays |
10/06/2011 | US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
10/06/2011 | US20110244519 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
10/06/2011 | US20110244518 Prokaryotic Expression of Soluble, Active Dkk |
10/06/2011 | US20110244517 System for antibody expression and assembly |
10/06/2011 | US20110244516 Rage Fusion Proteins And Methods Of Use |
10/06/2011 | US20110244515 Method of preparing protein having high content of specific amino acid by co-expression with trna of specific amino acid |